Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc

Sydney E Hartsell1,2,3, Stavros G Drakos2,3,4, Robert E Boucher1,2

  • 1Division of Nephrology & Hypertension, Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah.

Kidney Medicine
|June 30, 2026
PubMed

Insights

Chronic kidney disease (CKD) and depressive symptoms are independent risk factors for heart failure (HF). Patients with both conditions face a significantly increased risk of developing HF, highlighting the need for integrated care.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Psychiatry

Background:

  • Type 4 cardiorenal syndrome involves chronic kidney disease (CKD) leading to chronic heart failure (HF).
  • Depression is a potential contributing factor in the pathophysiology of CKD-related HF.
  • The combined impact of depressive symptoms and CKD on HF risk requires further investigation.

Purpose of the Study:

  • To determine if depressive symptoms and CKD are independent predictors of incident heart failure (HF).
  • To assess whether depressive symptoms and CKD augment HF risk when present concurrently.
  • To investigate the additive or synergistic effects of CKD and depression on HF development.

Main Methods:

  • A post-hoc analysis of data from the Systolic Blood Pressure Intervention Trial (SPRINT).
  • Included 8,930 participants without baseline HF, assessing depressive symptoms via Patient Health Questionnaire-9 (PHQ-9) and CKD status.
  • Utilized multivariable Cox proportional hazards regression models to analyze the association between PHQ-9 scores, CKD, and incident HF events.

Main Results:

  • Both CKD (Hazard Ratio [HR] 1.60) and severe depressive symptoms (PHQ-9 ≥ 5, HR 1.92) were independently associated with increased HF risk.
  • Participants with both CKD and severe depressive symptoms had a 3.45-fold increased hazard of HF compared to those with neither condition.
  • The risk factors appeared to act additively rather than synergistically.

Conclusions:

  • Chronic kidney disease (CKD) and significant depressive symptoms are independent risk factors for heart failure (HF).
  • The presence of both CKD and depressive symptoms significantly elevates the risk of HF.
  • Integrated management strategies addressing both cardiovascular and mental health are crucial for high-risk patients.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.